Drop-ins and research consultations
Business Data drop ins
Wednesday, 11am to 12pm, Precinct Library (term-time only)
Do you have a burning question about business data or how to use business resources?
- How do I use business databases?
- Where can I find information for my assignment?
- How can I learn how to use specialist databases such as Bloomberg or Datastream?
The Business Data drop-in gives you the opportunity to ask that question and find a solution. If we can’t answer your question, we’ll find someone who can.
These are quick informal sessions, there’s no need to book. They can get busy though (especially at the beginning of semester) so you may have to wait a little while, but we’ll answer your question as soon as possible.
We aim to answer as many queries as we can in the allocated hour. If you have a complex question that we can’t answer quickly, we’ll get back to you after the session with a comprehensive response or refer you to a research consultation.
The drop-in is open to all University of Manchester staff and students.
Please contact email@example.com for more details.
We offer drop-in sessions for your business data queries. Our Research Consultation sessions provide you with specialist help using our full suite of financial databases.
- Thursdays from 2.30pm to 4.30pm at Dover Street Building G.010 Database Suite
Come and visit us if you are having difficulty retrieving data from our databases. If you email your query in advance to firstname.lastname@example.org (and clearly mark your message "Research Consultation") then we will be able to help you better.
You may also request an appointment at another time by emailing email@example.com.
Examples of research consultation questions
- How do I get historical ownership relationship models for European private companies? (from Alliance Manchester Business School)
- Where can I find all University of Manchester alumni who are company board directors and their total wealth? (from Development and Alumni Relations office)
- What drug testing is currently in the pipeline for a specific pharmaceutical company? (from Research and Business Engagement Support office)